Te. Morgan et al., Transforming growth factor-beta 1 induces transforming growth factor-beta 1 and transforming growth factor-beta receptor messenger RNAs and reduces complement C1qB messenger RNA in rat brain microglia, NEUROSCIENC, 101(2), 2000, pp. 313-321
Transforming growth factor-beta1 is a multifunctional peptide with increase
d expression during Alzheimer's disease and other neurodegenerative conditi
ons which involve inflammatory mechanisms. We examined the autoregulation o
f transforming growth factor-beta1 and transforming growth factor-beta rece
ptors and the effects of transforming growth factor-beta1 on complement C1q
in brains of adult Fischer 344 male rats and in primary glial cultures. Pe
rforant path transection by entorhinal cortex lesioning was used as a model
for the hippocampal deafferentation of Alzheimer's disease. In the hippoca
mpus ipsilateral to the lesion, transforming growth factor-beta1 peptide wa
s increased >100-fold; the messenger RNAs encoding transforming growth fact
or-beta1, transforming growth factor-beta type I and type II receptors were
also increased, but to a smaller degree. In this acute lesion paradigm, mi
croglia are the main cell type containing transforming growth factor-beta1,
transforming growth factor-beta type I and II receptor messenger RNAs, sho
wn by immunocytochemistry in combination with in situ hybridization. Autore
gulation of the transforming growth factor-beta1 system was examined by int
raventricular infusion of transforming growth factor-beta1 peptide, which i
ncreased hippocampal transforming growth factor-beta1 messenger RNA levels
in a dose-dependent fashion. Similarly, transforming,orowth factor-beta1 in
creased levels of transforming growth factor-beta1 messenger RNA and transf
orming growth factor-beta type II receptor messenger RNA (IC50, 5 pM) and i
ncreased release of transforming growth factor-beta1 peptide from primary m
icroglia cultures. Interactions of transforming growth factor-beta1 with co
mplement system gene expression are also indicated, because transforming gr
owth factor-beta1 decreased C1qB messenger RNA in the cortex and hippocampu
s, after intraventricular infusion, and in cultured glia. These indications
of autocrine regulation of transforming growth factor-beta1 in the rodent
brain support a major role of microglia in neural activities of transformin
g growth factor-beta1 and give a new link between transforming growth facto
r-beta1 and the complement system. The auto-induction of the transforming g
rowth factor-beta1 system has implications for transgenic mice that overexp
ress transforming growth factor-beta1 in brain cells and for its potential
role in amyloidogenesis. (C) 2000 IBRO. Published by Elsevier Science Ltd.
All rights reserved.